The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in female sexual arousal disorder (FSAD) diagnosis

Journal of Sexual Medicine

Volumn 3, Issue 2, 2006, Pages 283-291

  Rellini, Alessandra ^a   Meston, Cindy ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Design; Examination diagnostic testing; Methodology of clinical trials; Physical; Psychological assessment of sexual dysfunction history; Psychophysiological studies of sexual function

Indexed keywords

GINKGO BILOBA EXTRACT; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; EVIDENCE BASED MEDICINE; FEMALE; FEMALE SEXUAL DYSFUNCTION; GENITAL SYSTEM EXAMINATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; ORGASM; PHOTOELECTRIC PLETHYSMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; SAMPLE SIZE; SCORING SYSTEM; SEMI STRUCTURED INTERVIEW; SENSITIVITY ANALYSIS; SEX THERAPY; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL SATISFACTION; SEXUALITY; TREATMENT OUTCOME; VALIDATION PROCESS; VIDEORECORDING;

EID: 33645969915     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2005.00153.x     Document Type: Article

References (20)

1. Meston CM. Female orgasmic disorder: Treatment strategies and outcome results. In: Goldstein I, Meston C, Davis S, Traish A, editors. Women's sexual function and dysfunction: Study, diagnosis and treatment. UK: Taylor & Francis (in press).
2. Rosen R, Barsky J. Psychological assessment and self-report questionnaires. In: Goldstein I, Meston C, Davis S, Traish A, editors. Women's sexual function and dysfunction: Study, diagnosis and treatment. UK: Taylor & Francis (in press).
3. FDA guidance document, guidance for industry: Female sexual dysfunction: Clinical development of drug products for treatment. 2000. Available at: http://www.fda.gov/cder/guidance/3312dft.htm.
4. Meston CM, Derogatis L. Validated Instruments for assessing female sexual function. J Sex Marital Ther 2002; 28: 155-64.
5. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R Jr. The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191-208.
6. Althof S, Rosen R, Derogatis L, Cortic E, Frances Q, Symonds T. Outcome measurement in female sexual dysfunction clinical trials. J Sex Marital Ther 2005; 31: 153-66.
7. Shifren J, Glenn BD, Simon JA, Casson PR, Buster JE, Redumond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682-8.
8. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient compliance with paper and electronic diaries. Control Clin Trials 2003; 24: 182-99.
9. Sintchak G, Geer JH. A vaginal plethysmograph system. Psychophysiology 1975; 12: 113-5.
10. Laan E, Everaerd W, Evers A. Assessment of female sexual arousal: Response specificity and construct validity. Psychophysiology 1995; 32: 476-85.
11. Meston CM, Gorzalka BB. The differentiated effects of sympathetic activation on sexual arousal in sexually functional and dysfunctional women. J Abnorm Psychol 1996; 105: 582-91.
12. Morokoff PJ, Heiman JR. Effects of erotic stimuli on sexually functional and dysfunctional women: Multiple measures before and after sex therapy. Behav Res Ther 1980; 18: 127-37.
13. Brotto LA, Basson R, Gorzalka BB. Psychophysiological assessment in premenopausal sexual arousal disorder. J Sex Med 2004; 1: 266-77.
14. Basson R, Leiblum S, Brotto L, DeRogatis L, Rourcroy J, Fugl-Meyer K, Graziottin A, Heiman JR, Laan E, Meston C, Schover L, van Lankveld J, Schultz WW. Definitions of women's sexual dysfunction reconsidered: Advocating expansion and revision. J Psychosom Obstet Gynaecol 2003; 24: 221-9.
15. Derogatis LR. The Derogatis interview for sexual functioning (DISF/ DISF-R): An introductory report. J Sex Marital Ther 1997; 23: 291-304.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition, text revised. Washington, DC: American Psychiatric Association; 2000.
17. Meston CM. Validation of the female sexual function index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 2003; 29: 39-46.
18. Wiegel M, Meston CM, Rosen R. The female sexual function index (FSFI): Cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31: 1-20.
19. Meston CM, Heiman JR. Ephedrine-activated physiological sexual arousal in women. Arch Gen Psychi 1998; 55: 652-6.
20. Rellini AH, McCall KM, Randall PK, Meston CM. The relationship between women's subjective and physiological sexual arousal. Psychophysiology 2005; 42: 116-24.